Medicare Enrolled

Dr. Pamela Schell Werschler, ARNP

Optician · Spokane, WA
Low-engagement
104 W 5TH AVE, Spokane, WA 99204
5096241184
In practice since 2007 (19 years)
NPI: 1578691028 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schell Werschler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schell Werschler? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schell Werschler

Dr. Pamela Schell Werschler is an optician specialist in Spokane, WA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Schell Werschler received a total of $6,064 from 18 pharmaceutical and/or device companies across 231 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schell Werschler is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $6,064 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,064
Total received (2021-2024)
Avg $1,516/year across 4 years
Top 16% in WA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
231
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,321 (71.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,742 (28.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,160
2023
$2,892
2022
$1,002
2021
$1,009

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$613
Lilly USA, LLC
$139
UCB, Inc.
$136
Janssen Biotech, Inc.
$60
Regeneron Healthcare Solutions, Inc.
$56
Amgen Inc.
$55
MERZ NORTH AMERICA, INC.
$42
Incyte Corporation
$23
Galderma Laboratories, L.P.
$22
Arcutis Biotherapeutics, Inc.
$14
Top 3 companies account for 76.5% of 2024 payments
All-time payments by company (2021-2024) ›
Merz North America, Inc.
$1,773
ABBVIE INC.
$1,743
Lilly USA, LLC
$431
Allergan, Inc.
$416
MERZ NORTH AMERICA, INC.
$298
AbbVie Inc.
$265
Janssen Biotech, Inc.
$188
Regeneron Healthcare Solutions, Inc.
$176
UCB, Inc.
$175
Amgen Inc.
$129
LEO Pharma Inc.
$111
Biofrontera Inc.
$104
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Incyte Corporation
$67
Galderma Laboratories, L.P.
$54
Sun Pharmaceutical Industries Inc.
$37
Arcutis Biotherapeutics, Inc.
$14
GENZYME CORPORATION
$14
Top 3 companies account for 65.1% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · BOTOX · Bimzelx · Cimzia · DUPIXENT · HUMIRA · ILUMYA · LIBTAYO · OLUMIANT · OPZELURA · Otezla · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · TALTZ · TREMFYA · Xeomin · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Spokane?
Compare opticians in the Spokane area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
193
Per 100K population
35.5
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schell Werschler is an optician specialist, with low-engagement industry engagement in the top 16% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Schell Werschler receive payments from pharmaceutical companies?
Yes. Dr. Schell Werschler received a total of $6,064 from 18 companies across 231 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Schell Werschler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Opticians in Spokane
Browse opticians in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Opticians in WA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in WA
Which WA opticians receive the most from drug and device companies.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →